Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 17Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 10Myeloid 8Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × nilotinib × Sarcoma × Clear all
NCT00976612 2020-01-07

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Asan Medical Center

Completed
17 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡